| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/06/2012 | CN102008496B Medicament for treating breast cancer and preparation method thereof |
| 06/06/2012 | CN101972435B Traditional Chinese medicine for treating malnutrition and indigestion in children and preparation method thereof |
| 06/06/2012 | CN101972247B Medicinal application of 15-benzyl subunit-1 4-deoxy-11,12-dehydrogenation andrographolide derivative |
| 06/06/2012 | CN101953982B Traditional Chinese medicine plaster for treating chronic pyelonephritis |
| 06/06/2012 | CN101953910B Coptis alkaloid and ferulic acid compound with glucose-lowering effect |
| 06/06/2012 | CN101948428B 1-methyl-5H-indene (1,2-b) pyridine trifluoromethanesulfonic salt-5-(4-dimethylamino group) benzylidene derivative and preparation method thereof |
| 06/06/2012 | CN101920019B Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate |
| 06/06/2012 | CN101874790B Orally disintegrating tablet of Rasagiline or medicine salts thereof and preparation method thereof |
| 06/06/2012 | CN101856495B Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof |
| 06/06/2012 | CN101856329B Rizatriptan benzoate oral spray |
| 06/06/2012 | CN101849902B Preparation method of solid pharmaceutical composition containing desloratadine |
| 06/06/2012 | CN101848893B 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
| 06/06/2012 | CN101843891B Blood tonifying composition |
| 06/06/2012 | CN101816797B Gold nanoparticles used as medicament carrier and method for preparing same |
| 06/06/2012 | CN101791313B Application of calcium disodium edentate and corticosteroid compound preparation in preparing medicine capable of inhibiting connective tissue growth factors and monoamine oxidase |
| 06/06/2012 | CN101775026B Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof |
| 06/06/2012 | CN101744790B Method for preparing stable-type vitamin A microcapsules continuously |
| 06/06/2012 | CN101721416B Huperzine A solid composition and preparation method thereof |
| 06/06/2012 | CN101703782B Method for preparing nano-prodrug of nucleoside phosphorus acylation coupled chitosan derivative and application thereof |
| 06/06/2012 | CN101694487B Screening method, extracting method, content measuring method and application of glycyrrhisoflavone in liquorice |
| 06/06/2012 | CN101693017B Medicament composition of levetiracetam and preparation process |
| 06/06/2012 | CN101690812B Concentrated freeze-dried yolk antibody composite preparation for Newcastle disease-infectious bursal disease and preparation process thereof |
| 06/06/2012 | CN101679396B Triazolyl aminopyrimidine compounds |
| 06/06/2012 | CN101663301B Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists |
| 06/06/2012 | CN101659706B Method for purifying and separating X-fraction polysaccharide from fruit bodies or mycelia of polyporus frondosus |
| 06/06/2012 | CN101657449B Diphenyl-dihydro-imidazopyridinones |
| 06/06/2012 | CN101648008B Compound preparation used for joint care and preparation method thereof |
| 06/06/2012 | CN101638404B High-purity salvianolic acid B and preparation method and application thereof |
| 06/06/2012 | CN101585809B Novel compound with antibacterial and antitumor activities |
| 06/06/2012 | CN101573115B Method for prevention of coloration in donepezil-containing skin adhesive preparation, and method for reducing the production of donepezil analogue |
| 06/06/2012 | CN101568543B Macrocyclic peptides as hepatitis c virus inhibitors |
| 06/06/2012 | CN101553225B The uses of the carboxy-amido-triazole compounds |
| 06/06/2012 | CN101550118B Synthetic process for vitamin C sodium salts |
| 06/06/2012 | CN101537006B Application of pyridazinone compounds in preparing antitumor drugs |
| 06/06/2012 | CN101528714B Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one |
| 06/06/2012 | CN101524546B Conjugate conjugated from polyethylene glycol and curcumin derivative |
| 06/06/2012 | CN101522668B Oxyindole derivatives as 5ht4 receptor agonists |
| 06/06/2012 | CN101522188B Anti-cancer agent |
| 06/06/2012 | CN101511369B Methods and compositions for inhibiting angiogenesis. |
| 06/06/2012 | CN101478960B Compounds A-R-X for the manufacture of pharmaceutical preparations |
| 06/06/2012 | CN101472904B Diazepan derivatives modulators of chemokine receptors |
| 06/06/2012 | CN101455399B Linoleate preparation method using highland barley bran oil |
| 06/06/2012 | CN101444570B Niuhuangshangqing soft capsule and preparation method thereof |
| 06/06/2012 | CN101440116B Glycyrrhizin, preparation and use thereof |
| 06/06/2012 | CN101417995B Phenoxy pyrimidine derivates and preparation method and use thereof |
| 06/06/2012 | CN101416964B Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus |
| 06/06/2012 | CN101379024B Process for manufacturing entacapone |
| 06/06/2012 | CN101365798B Novel K04-0144 substance and preparation thereof |
| 06/06/2012 | CN101300010B Pharmaceutical preparation having excellent photostability |
| 06/06/2012 | CN101228183B Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold |
| 06/06/2012 | CN101224247B Chinese traditional medicine compounds for treating Alzheimer's disease and preparing method thereof |
| 06/06/2012 | CN101217874B Method of treating or preventing bone deterioration or osteoporosis |
| 06/06/2012 | CN101213192B Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 06/06/2012 | CN101213187B Isoquinoline derivatives as inhibitors of RHO-kinase |
| 06/06/2012 | CN101193624B Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying |
| 06/06/2012 | CN101189210B Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPTl) inhibitors |
| 06/06/2012 | CN101175506B Method for preparing a ginkgo extract having a reduced content of 4'-o-methyl pyridoxine and/or biflavones |
| 06/06/2012 | CN101151034B Meninges nerve cell protector containing prostaglandin F2alpha derivative as effective component |
| 06/06/2012 | CN101142182B Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as MAOB inhibitors |
| 06/06/2012 | CN101141946B Use of silymarine and/or the constituents thereof as promoters of the pigmentation of the skin or hair |
| 06/06/2012 | CN101098855B 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/06/2012 | CN101087758B Indole derivatives useful as progesterone receptor modulators |
| 06/06/2012 | CN101084997B Traditional Chinese medicine freezing-dried powder injection for treating cardiovascular and cerebrovascular diseases and its preparing method |
| 06/06/2012 | CN101060863B Modulation of neuroglia-derived BDNF in the treatment and prevention of pain |
| 06/06/2012 | CN101039933B Diaminotriazole compounds useful as protein kinase inhibitors |
| 06/06/2012 | CN101035773B HIV inhibiting 1.2.4-triazin-6-one derivates |
| 06/05/2012 | US8193389 N-substituted benzene sulfonamides |
| 06/05/2012 | US8193372 Phosphothiophene and phosphothiazole HCV polymerase inhibitors |
| 06/05/2012 | US8193369 Benzimidazole cannabinoid agonists |
| 06/05/2012 | US8193367 Polymorph of a pharmaceutical |
| 06/05/2012 | US8193360 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 06/05/2012 | US8193359 G-protein coupled receptor agonists |
| 06/05/2012 | US8193356 Heterocycle compound, and production process and application thereof |
| 06/05/2012 | US8193352 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections |
| 06/05/2012 | US8193351 HSP90 inhibitor |
| 06/05/2012 | US8193340 Preparation method of porous hyaluronic acid sponge for cell delivery system |
| 06/05/2012 | US8193338 Process for producing di(pyrimidine nucleoside 5'-)polyphosphate |
| 06/05/2012 | US8193332 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 06/05/2012 | US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 06/05/2012 | US8193317 Freeze-dried fibrin matrices and methods for preparation thereof |
| 06/05/2012 | US8193252 Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
| 06/05/2012 | US8193250 Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system |
| 06/05/2012 | US8193249 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 06/05/2012 | US8193248 Contraceptive composition |
| 06/05/2012 | US8193247 Phenolic hydrazone macrophage migration inhibitory factor inhibitors |
| 06/05/2012 | US8193246 Lipids and lipid assemblies comprising transfection enhancer elements |
| 06/05/2012 | US8193245 prevention or treatment of degenerative brain diseases; Cis-9-octadecenoic acid |
| 06/05/2012 | US8193244 Antimicrobial agents |
| 06/05/2012 | US8193243 Continuous administration of dopa decarboxylase inhibitors and compositions for same |
| 06/05/2012 | US8193242 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 06/05/2012 | US8193241 Discodermolide analogues and methods of their use |
| 06/05/2012 | US8193240 Compositions and methods for reducing or preventing obesity |
| 06/05/2012 | US8193239 Substituted 1-cyanoethylheterocyclylcarboxamide compounds |
| 06/05/2012 | US8193238 Inhibition of microtubule protrusion in cancer cells |
| 06/05/2012 | US8193237 Indole derivative having IκB kinase β inhibitory activity |
| 06/05/2012 | US8193236 Indolylmaleimide derivatives processes for their production and pharmaceutical compositions |
| 06/05/2012 | US8193235 Compositions and methods for establishing and maintaining stem cells in an undifferentiated state |
| 06/05/2012 | US8193234 Compounds, compositions and methods of using same for modulating uric acid levels |
| 06/05/2012 | US8193233 Anti-fungal formulation |
| 06/05/2012 | US8193232 Anti-fungal formulation |